Skip to content
Menu

Fennec Pharmaceuticals Inc. FRX.TO

Full chart Compare
Set alert

Price alert · FRX.TO

All alert types
18.35 CAD +1.79 (+10.81%)

As ofNov 16, 2026, 3:59 PM EST

16.24 Day range 18.35
7.59 52-week range 18.35
YTD
+73.11%
1 year
+64.57%
Market cap
647.85M
Revenue (ttm)
49.35M
Profit margin
-2.30%
EPS (ttm)
0.04
Shares out
27.43M
P/E ratio
458.75
YTD return
+73.11%
1-year return
+64.57%
Volume
591
Avg volume
430
Open
16.24
Previous close
16.56
Day's range
16.24 – 18.35
52-week range
7.59 – 18.35
Beta
0.27
50-day average
7.13

 

No chart data for this range yet.

Key statistics

200-day average
9.13
Enterprise value
226.88M
Price / sales
4.95
Revenue growth
7.00%
Free cash flow
-3.40M
Total cash
40.32M
Total debt
32.10M
Short % of float
0.13%

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on FRX.TO — it syncs with the Stock Master app.

Insider holders

FRX.TO insider holders
InsiderRelationLatest transactionDateShares held
ANDRADE ROBERT CChief Financial OfficerStock Award(Grant)Dec 1, 2024128,423
HAIGH ADRIAN JChief Operating OfficerSaleApr 21, 20240
ISLAM KHALIDDirectorConversion of Exercise of derivative securityNov 15, 2023213,825
RALLIS CHRISTOPHER ANIGERONDirectorSaleDec 1, 202452,214
RAYKOV ROSTISLAV CHRISTOVDirectorSaleDec 4, 202466,432

Institution ownership

FRX.TO institution ownership
Holder% heldSharesValueReported
Southpoint Capital Advisors Lp14.84%4,077,21436.33MSep 29, 2024
Sonic Gp LLC 8.76%2,407,35721.45MSep 29, 2024
Solas Capital Management, LLC7.00%1,923,53617.14MSep 29, 2024
DG Capital Management, LLC5.54%1,522,20413.56MSep 29, 2024
Blackrock Inc.4.48%1,229,47710.95MSep 29, 2024
Vanguard Group Inc3.81%1,047,8919.34MSep 29, 2024

Fund ownership

FRX.TO fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund3.19%876,2087.81MSep 29, 2024
iShares Russell 2000 ETF2.04%559,3714.98MOct 30, 2024
Fidelity Small Cap Index Fund0.88%241,0182.15MAug 30, 2024
iShares Russell 2000 Value ETF0.60%165,5101.47MOct 30, 2024
Vanguard Russell 2000 Index Fund0.34%94,580842.71KAug 30, 2024
Schwab Capital Trust-Small Cap Index Fund0.20%55,452494.08KJul 30, 2024